BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Ocugen, Inc. Announces Closing of $22.5 Million Underwritten Registered Direct Offering of Common Stock

  January 26, 2026

   · 

  3 min read
• Press Releases

  Enlivex Therapeutics Shares to Trade Exclusively on Nasdaq

  January 26, 2026

   · 

  5 min read
• Press Releases

  Daxor Corporation Announces $9 Million Registered Direct Offering

  January 26, 2026

   · 

  3 min read
• Press Releases

  Bausch Health Provides Update on RED-C Phase 3 Clinical Trials

  January 26, 2026

   · 

  3 min read
• Press Releases

  Altamira Therapeutics to Present at mRNA-Based Therapeutics Summit

  January 26, 2026

   · 

  4 min read
• Press Releases

  Enovis to Host Fourth Quarter and Full Year 2025 Results Conference Call on February 26th

  January 26, 2026

   · 

  1 min read
• Press Releases

  FDA Accepts LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease under Priority Review

  January 26, 2026

   · 

  20 min read
• Press Releases

  BlueOcean Global Announces FDA 510(k) Clearance of the Excelsior™ External Fixation System

  January 26, 2026

   · 

  1 min read
• Press Releases

  Optimi Health Completes First 2026 Production of MDMA and Psilocybin Capsules

  Australia’s Department of Health has issued import permits for Optimi’s MDMA and psilocybin capsules for use under the Authorised Prescriber Scheme

  January 26, 2026

   · 

  1 min read
• Press Releases

  Organoid : Organ or Model? Navigating the Scientific Hype - Commentary by Unexakorea

  January 26, 2026

   · 

  1 min read